Abstract
Background
The clinical practice of sentinel lymph node biopsy for breast cancer patients started in 1999 in our hospital, to obviate unnecessary axillary lymph node dissection. The present study examines the pathological false-negative cases on intraoperative sentinel lymph node investigations and evaluates their outcomes.
Methods
The subjects consisted of 183 cases with clinically node-negative breast cancer who had undergone sentinel node biopsy. When the sentinel node was noted to contain malignant cells intraoperatively, a complete axillary lymph node dissection was performed subsequently. The patients with tumor free sentinel nodes underwent no further axillary surgery. The pathological false-negative cases in this series were defined as patients with lymph node involvement which was revealed postoperatively, despite negative intraoperative sentinel node examinations. After these surgeries and/or adjuvant therapies, interval clinical evaluations were performed for all patients.
Result
Intraoperative diagnosis of the sentinel node was 96.2% accurate compared with the results of permanent sections. There were six pathological false-negative cases, a false-negative rate of 4.1%, all of which had only micrometastasis. Five cases received systemic adjuvant therapy and have been disease-free, however, one patient who refused further therapy developed infraclavicular lymph node metastasis two years after surgery.
Conclusions
In the management of the patients with postoperatively revealed sentinel node micrometastasis, systemic adjuvant therapies might reduce local relapse without secondary lymph node dissection.
Similar content being viewed by others
Abbreviations
- HE:
-
Hematoxylin and Eosin
- IHC:
-
Immunohistochemistry
- CMF:
-
Cyclophosphamide-Methotrexate-Fluorouracil therapy
- TAM:
-
Tamoxifen
- DCIS:
-
Ductal carcinomain situ
References
Cabanas RM: An approach for the treatment of penile carcinoma.Cancer 39:456–466, 1977.
The World Health Organization: Histological typing of breast tumors.Neoplasma 30:113–123, 1983.
Liberman L: Pathologic analysis of sentinel lymph nodes in breast carcinoma.Cancer 88:971–977, 2000.
Krag DN, Weaver DL, Alex JC, Fairbank JT: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe.Surg Oncol 2:335–339, 1993.
Giuliano AE, Kirgan DM, Guenther JM, Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer.Ann Surg 220:391–401, 1994.
Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, Shivers S, Berman C, Wells K, Rapaport D, Shons A, Horton J, Greenberg H, Nicosia S, Clark R, Cantor A, Reintgen DS: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer.JAMA 276:1818–1822, 1996.
Motomura K, Inaji H, Komoike Y, Kasugai T, Nagumo S, Noguchi S, Koyama H: Intraoperative sentinel lymph node examination by imprint cytology and frozen sectioning during breast surgery.Br J Surg 87:597–601, 2000.
Kane JM, Edge SB, Winston JS, Watroba N, Hurd TC: Intraoperative pathologic evaluation of a breast cancer entinel lymph node biopsy as a determinant for synchronous axillary lymph node dissection.Ann Surg Oncol 8:361–367, 2001.
Rubio IT, Korourian S, Cowan C, Krag DN, Colvert M, Klimberg VS: Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer.Ann Surg Oncol 5:689–694, 1998.
Van Diest PJ, Torrenga H, Borgstein PJ, Pijpers R, Bleichrodt RP, Rahusen FD, Meijer S: Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer.Histopathology 35:14–18, 1999.
Noguchi M, Tsugawa K, Kawahara F, Bando E, Miwa K, Minato H, Nonomura A: Dye-Guided Sentinel Lymphadenectomy in Clinically Node-Negative and Node-Positive Breast Cancer Patients.Breast Cancer 5:381–387, 1998.
Cserni G: The potential value of intraoperative imprint cytology of axillary sentinel lymph nodes in breast cancer patients.Am Surg 67:86–91, 2001.
Ratanawichitrasin A, Biscotti CV, Levy L, Crowe JP: Touch imprint cytological analysis of sentinel lymph nodes for detecting axillary metastases in patients with breast cancer.Br J Surg 86:1346–1348, 1999.
Weaver DL, Krag DN, Ashikaga T, Harlow SP, O’Connell M: Pathologic analysis of sentinel and non-sentinel lymph nodes in breast carcinoma: a multicenter study.Cancer 88:1099–1107, 2000.
Borgstein PJ, Meijer S, Pijpers R: Intradermal blue dye to identify sentinel lymph-node in breast cancer.Lancet 349:1668–1669, 1997.
Giuliano AE, Jones RC, Brennan M, Statman R: Sentinel lymphadenectomy in breast cancer.J Clin Oncol 15:2345–2350, 1997.
Veronesi U, Paganelli G, Galimberti V, Viale G, Zurri-da S, Bedoni M, Costa A, de Cicco C, Geraghty JG, Luini A, Sacchini V, Veronesi P: Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.Lancet 349:1864–1867, 1997.
Guenther JM, Krishnamoorthy M, Tan LR: Sentinel lymphadenectomy for breast cancer in a community managed care setting.Cancer J Sci Am 3:336–340, 1997.
Offodile R, Hoh C, Barsky SH, Nelson SD, Elashoff R, Eilber FR, Economou JS, Nguyen M: Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled dextran.Cancer 82:1704–1708, 1998.
Nano MT, Kollias J, Farshid G, Gill PG, Bochner M: Clinical impact of false-negative sentinel node biopsy in primary breast cancer.Br J Surg 89:1430–1434, 2002.
Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, Feldman S, Kusminsky R, Gadd M, Kuhn J, Harlow S, Beitsch P: The sentinel node in breast cancer-a multicenter validation study.N Engl J Med 339:941–646, 1998.
Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, Ku NN, Lyman GH, Berman C, Haddad F, Reintgen DS: Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer.Ann Surg 227:645–653, 1998.
Hill AD, Tran KN, Akhurst T, Yeung H, Yeh SD, Rosen PP, Borgen PI, Cody HS 3rd: Lessons learned from 500 cases of lymphatic mapping for breast cancer.Ann Surg 229:528–535, 1999.
Nieweg OE, Rutgers EJ, Jansen L, Valdes Olmos RA, Peterse JL, Hoefnagel KA, Kroon BB: Is lymphatic mapping in breast cancer adequate and safe?World J Surg 25:780–788, 2001.
Jakub JW, Diaz NM, Ebert MD, Cantor A, Reintgen DS, Dupont EL, Shons AR, Cox CE: Completion axillary lymph node dissection minimizes the likelihood of false negatives for patients with invasive breast carcinoma and cytokeratin positive only sentinel lymph nodes.Am J Surg 184:302–306, 2002.
Turner RR, Chu KU, Qi K, Botnick LE, Hansen NM, Glass EC, Giuliano AE: Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node.Cancer 89:574–581, 2000.
Rahusen FD, Torrenga H, van Diest PJ, Pijpers R, van derWallE, Licht J, Meijer S: Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer.Arch Surg 136:1059–1063, 2001.
Todd JH, Dowle C, Williams MR, Elston CW, Ellis IO, Hinton CP, Blarney RW, Haybittle JL: Confirmation of a prognostic index in primary breast cancer.Br J Cancer 56:489–492, 1987.
Forrest AP, Everington D, McDonald CC, Steele RJ, Chetty U, Stewart HJ: The Edinburgh randomized trial of axillary sampling or clearance after mastectomy.Br J Surg 82:1504–1508, 1995.
Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham DL, Deutsch M, Montague E, Mar-golese R, Foster R: Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation.N Engl J Med 312:674–681, 1985.
Chu KU, Turner RR, Hansen NM, Brennan MB, Bilchik A, Giuliano AE: Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?Ann Surg 229:536–541, 1999.
Guenther JM, Hansen NM, DiFronzo LA, Giuliano AE, Collins JC, Grube BL, O’Connell TX: Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes.Arch Surg 138:52–56, 2003.
Chu KU, Turner RR, Hansen NM, Brennan MB, Giuliano AE: Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohisto-chemically detectable nonsentinel node metastasis.Ann Surg Oncol 6:756–761, 1999.
Reynolds C, Mick R, Donohue JH, Grant CS, Farley DR, Callans LS, Orel SG, Keeney GL, Lawton TJ, Czerniecki BJ: Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer?Clin Oncol 17:1720–1726 1999.
Czerniecki BJ, Scheff AM, Callans LS, Spitz FR, Bedrosian I, Conant EF, Orel SG, Berlin J, Helsabeck C, Fraker DL, Reynolds C: Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma.Cancer 85:1098–1103,1999.
Author information
Authors and Affiliations
About this article
Cite this article
Nagashima, T., Yagata, H., Nikaido, T. et al. Follow-up of cases with false-negative pathologic sentinel nodes in breast cancer. Breast Cancer 11, 175–179 (2004). https://doi.org/10.1007/BF02968298
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02968298